Comparison of volume-reductive therapies for massive XXXX in @entity8 .

@entity1 @entity8 @entity353 @entity409 @entity1416 @entity1578 @entity382
AIM: @entity409 ( @entity409 ) in @entity8 ( @entity8 ) @entity1 can induce massive @entity382 . Volume-reductive therapies for symptomatic @entity409 include transcatheter @entity1416 (TAE), liver resection and liver transplantation; however, consensus has not been reached regarding treatment selection. We compared three volume-reductive therapies for a better understanding of @entity409 treatment strategies. METHODS: We retrospectively analyzed 28 @entity8 @entity1 who underwent TAE, liver resection or liver transplantation for @entity409 at a single center, and compared their outcomes. RESULTS: Of 18 TAE @entity1 , five required repeat TAE, and five required rescue liver transplantation or liver resection because of refractory symptoms or @entity1578 . The treatment failure rate for TAE was high (69.6%). Nine underwent liver resection, and the degree of @entity353 in the liver resection group was greater than that in the TAE group (52.4% vs 7.6%, P   <  0.001). One liver resection @entity1 required rescue liver transplantation because of @entity1578 . Seven @entity1 underwent liver transplantations. All liver transplant @entity1 had successfully controlled symptoms or @entity1578 , and had good graft function. Three @entity1 in the TAE group died of infections or @entity1578 , whereas no mortality occurred after surgical therapy. CONCLUSION: Liver resection is a good first-line therapy in @entity1 that have severe symptoms, cyst involvement in several segments with some spared segments and preserved liver function. Liver transplantation is a preferred first-line therapy in @entity1 with poor liver function or whole-liver involvement. Liver transplantation is also a good rescue therapy following TAE or liver resection.
